Diagnosis and Differential Diagnosis



Download 340.86 Kb.
Page1/4
Date conversion04.06.2018
Size340.86 Kb.
  1   2   3   4
Diagnosis and Differential Diagnosis
Co-occurrence of multiple sclerosis and Parkinson disease.

Shaygannejad V, Shirmardi M, Dehghani L, Maghzi H.

Adv Biomed Res. 2016 Apr 21;5:75. doi: 10.4103/2277-9175.180993. eCollection 2016.
Immune Rebound: Multiple Sclerosis after Treatment of Cushing's Disease.

Soveid M, Petramfar P.

Iran J Immunol. 2016 Mar;13(1):64-8. doi: IJIv13i1A8. No abstract available.
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.

Montgomery S, Hajiebrahimi M, Burkill S, Hillert J, Olsson T, Bahmanyar S.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 14;3(3):e227. doi: 10.1212/NXI.0000000000000227. eCollection 2016 Jun.
Optic Nerve Sheath Meningioma Masquerading as Optic Neuritis.

Alroughani R, Behbehani R.

Case Rep Neurol Med. 2016;2016:5419432. doi: 10.1155/2016/5419432. Epub 2016 Jan 19
Mohebi N, Moghaddasi M, Maryam Z.

Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.

Neurol Int. 2015 Sep 24;7(2):5966. doi: 10.4081/ni.2015.5966. eCollection 2015 Sep 24.

Alroughani RA, Ahmed SF, Khan RA, Al-Hashel JY.


Spinal segmental myoclonus as an unusual presentation of multiple sclerosis. 
BMC Neurol. 2015 Feb 27;15:15. doi: 10.1186/s12883-015-0271-y.

Harirchian MH, Tafakhori A, Taslimi S, Aghamollaii V, Shahsiah R, Gholipour T, Mohammadi F, Zare-Shahabadi A.


Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
Iran J Allergy Asthma Immunol. 2015 Feb;14(1):98-104.

Alroughani R, Ahmed SF, Khan R, Al-Hashel J.


Status migrainosus as an initial presentation of multiple sclerosis.
Springerplus. 2015;4:28. doi: 10.1186/s40064-015-0818-9.

Eshaghi A, Riyahi-Alam S, Saeedi R, Roostaei T, Nazeri A, Aghsaei A, Doosti R, Ganjgahi H, Bodini B, Shakourirad A, Pakravan M, Ghana'ati H, Firouznia K, Zarei M, Azimi AR, Sahraian MA.


Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis.
Neuroimage Clin. 2015;7:306-14. doi: 10.1016/j.nicl.2015.01.001.

Fallahi-Khoshknab M, Ghafari S, Nourozi K, Mohammadi E.


Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
J Nurs Res. 2014 Dec;22(4):275-82. doi: 10.1097/jnr.0000000000000058.

Etemadifar M, Janghorbani M, Koushki MM, Etemadifar F, Esfahani MF.


Conversion from radiologically isolated syndrome to multiple sclerosis.
Int J Prev Med. 2014 Nov;5(11):1379-86.

Sennou AS, Boujraf S, Belahsen MF, Messouak O.


Psychiatric disorders revealing multiple sclerosis after 20 years of evolvement.
J Neurosci Rural Pract. 2014 Oct;5(4):420-2. doi: 10.4103/0976-3147.140009.

Naghshineh H, Shahin D, Sahraian MA, Minagar A.


Co-existence of neurofibromatosis type 2 and multiple sclerosis: A case report.
Mult Scler Relat Disord. 2014 May;3(3):384-6. doi: 10.1016/j.msard.2013.08.008. Epub 2013 Nov 7.

Nikseresht A, Sharifian M, Izadi S, Hamidian Jahromi A, Rezaianzadeh A.


Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis?
Clin Neurol Neurosurg. 2014 Jun;121:23-6. doi: 10.1016/j.clineuro.2014.03.015. Epub 2014 Mar 19.

Etemadifar M, Mehrbod N, Dehghani L, Golabbakhsh A, Fereidan-Esfahani M, Akbari M, Nasr Z.


Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica.
Iran J Neurol. 2014;13(1):50-1. No abstract available. 

Akhtar N, Elsetouhy A, Deleu D, Kamran S, AlHail H, Elalamy O, Mesraoua B, Sokrab T, Kamil H, Melikyan G, D'souza A, Osman Y, Imam Y.


Newly diagnosed multiple sclerosis in state of Qatar.
Clin Neurol Neurosurg. 2013 Aug;115(8):1333-7. doi: 10.1016/j.clineuro.2012.12.035. Epub 2013 Feb 5.

Sawaya R, Radwan W.


Sarcoidosis associated with neuromyelitis optica.
J Clin Neurosci. 2013 Aug;20(8):1156-8. doi: 10.1016/j.jocn.2012.09.030. Epub 2013 May 15.

Epidemiology and Risk Factors

Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province.

Rejali M, Hosseini SM, Kazemi Tabaee MS, Etemadifar M.

Int J Prev Med. 2016 Mar 10;7:58. doi: 10.4103/2008-7802.178532. eCollection 2016.
Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.

Etemadifar M, Nourian SM, Nourian N, Abtahi SH, Sayahi F, Saraf Z, Fereidan-Esfahani M.

J Child Neurol. 2016 Jun;31(7):932-7. doi: 10.1177/0883073816634853. Epub 2016 Mar 15.
Effect of smoking on multiple sclerosis: a meta-analysis.

Poorolajal J, Bahrami M, Karami M, Hooshmand E.

J Public Health (Oxf). 2016 May 8. pii: fdw030. [Epub ahead of print].
Multiple Sclerosis Epidemiology in East Asia, South East Asia and South Asia: A Systematic Review.

Eskandarieh S, Heydarpour P, Minagar A, Pourmand S, Sahraian MA.

Neuroepidemiology. 2016;46(3):209-21. doi: 10.1159/000444019. Epub 2016 Feb 19.
Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence.

Nasr Z, Majed M, Rostami A, Sahraian MA, Minagar A, Amini A, McGee JC, Etemadifar M.

Neurol Sci. 2016 Jun 28. [Epub ahead of print] Review.
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.

El-Tallawy HN, Farghaly WM, Badry R, Metwally NA, Shehata GA, Rageh TA, El Hamed MA, Kandil MR.

Neuropsychiatr Dis Treat. 2016 Jan 13;12:155-8. doi: 10.2147/NDT.S87348. eCollection 2016.
Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait.

Akhtar S, Alroughani R, Ahmed SF, Al-Hashel JY.

Neuroepidemiology. 2016;46(3):203-8. doi: 10.1159/000444185. Epub 2016 Feb 17.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.

Mohammadbeigi A, Kazemitabaee M, Etemadifar M.

Arch Womens Ment Health. 2016 Jan 20. [Epub ahead of print].
The environmental risk factors in multiple sclerosis susceptibility: A case-control study.

Shaygannejad V, Rezaie N, Paknahad Z, Ashtari F, Maghzi H.

Adv Biomed Res. 2016 Jun 8;5:98. doi: 10.4103/2277-9175.183665. eCollection 2016.
The role of Candida albicans in the severity of multiple sclerosis.

Saroukolaei SA, Ghabaee M, Shokri H, Ghaffarpour M, Badiei A.

Mycoses. 2016 Apr 8. doi: 10.1111/myc.12489. [Epub ahead of print]
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran.

Najafi S, Ghane M, Yousefzadeh-Chabok S, Amiri M.

Jundishapur J Microbiol. 2016 Mar 12;9(3):e34158. doi: 10.5812/jjm.34158. eCollection 2016 Mar.
Vitamin D3 attenuates oxidative stress and cognitive deficits in a model of toxic demyelination.

Tarbali S, Khezri S.

Iran J Basic Med Sci. 2016 Jan;19(1):80-8.
25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study.

Karampoor S, Zahednasab H, Ramagopalan S, Mehrpour M, Safarnejad Tameshkel F, Keyvani H.

J Neuroimmunol. 2016 Jan 15;290:47-8. doi: 10.1016/j.jneuroim.2015.11.017. Epub 2015 Nov 29.
Sidhom Y, Kacem I, Bayoudh L, Ben Djebara M, Hizem Y, Ben Abdelfettah S, Gargouri A, Gouider R.

Season of birth and multiple sclerosis in Tunisia.

Mult Scler Relat Disord. 2015 Nov;4(6):491-4. doi: 10.1016/j.msard.2015.08.002. Epub 2015 Aug 13.
Alharbi FM.

Update in vitamin D and multiple sclerosis.

Neurosciences (Riyadh). 2015 Oct;20(4):329-35. doi: 10.17712/nsj.2015.4.20150357.

Izadi S Md, Nikseresht AR Md, Poursadeghfard M Md, Borhanihaghighi A Md, Heydari ST PhD.

Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran.

Iran J Med Sci. 2015 Sep;40(5):390-5.


Mehrabi F, Asgari A.

Resistant Strains of Enterotoxigenic Staphylococcus aureus; Unknown Risk for Multiple SclerosisExacerbation.

Iran Red Crescent Med J. 2015 Sep 1;17(9):e12596. doi: 10.5812/ircmj.12596. eCollection 2015 Sep.
Mohammadi K, Rahnama P, Montazeri A.

Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.

Ann Gen Psychiatry. 2015 Sep 22;14:29. doi: 10.1186/s12991-015-0069-8. eCollection 2015.

Al-Temaimi R, Alroughani R, Jacob S, Al-Mulla F.


Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait.
J Neuroimmunol. 2015 Aug 15;285:57-61. doi: 10.1016/j.jneuroim.2015.05.021. Epub 2015 May 21.

Al-Shammri SN, Hanna MG, Chattopadhyay A, Akanji AO.


Sociocultural and Demographic Risk Factors for the Development of Multiple Sclerosis in Kuwait: A Case - Control Study.
PLoS One. 2015 Jul 1;10(7):e0132106. doi: 10.1371/journal.pone.0132106. eCollection 2015.

Heydarpour P, Khoshkish S, Abtahi S, Moradi-Lakeh M, Sahraian MA.


Multiple Sclerosis Epidemiology in Middle East and North Africa: A Systematic Review and Meta-Analysis. 
Neuroepidemiology. 2015;44(4):232-44. doi: 10.1159/000431042. Epub 2015 Jun 16.

Mouhieddine TH, Darwish H, Fawaz L, Yamout B, Tamim H, Khoury SJ.


Risk factors for multiple sclerosis and associations with anti-EBV antibody titers. 
Clin Immunol. 2015 May;158(1):59-66. doi: 10.1016/j.clim.2015.03.011. Epub 2015 Mar 21.

Zakaria M.


Smoke and mirrors: Limited value of relative risk reductions for assessing the benefits of disease-modifying therapies for multiple sclerosis. 
Mult Scler Relat Disord. 2015 May;4(3):187-91. doi: 10.1016/j.msard.2015.03.009. 

Eskandari G, Ghajarzadeh M, Yekaninejad MS, Sahraian MA, Gorji R, Rajaei F, Norouzi-Javidan A, Faridar A, Azimi A.


Comparison of serum vitamin D level in multiple sclerosis patients, their siblings, and healthy controls. 
Iran J Neurol. 2015 Apr 4;14(2):81-5.

Etemadifar M, Nasr Z, Khalili B, Taherioun M, Vosoughi R.


Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis. 
Mult Scler Int. 2015;2015:174720. doi: 10.1155/2015/174720. Epub 2015 Apr 20. Review

Akhtar S, Alroughani R, Al-Shammari A, Al-Abkal J, Ayad Y.


Month of birth and risk of multiple sclerosis in Kuwait: a population-based registry study.
Mult Scler. 2015 Feb;21(2):147-54. doi: 10.1177/1352458514541578. Epub 2014 Aug 4.

Nikanfar M, Taheri-Aghdam AA, Yazdani M, Shaafi S, Masoudian N, Akbari H, Youhanaee P, Abbaszadeh H.


Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Iran J Neurol. 2015 Jan 5;14(1):17-21.

Etemadifar M, Dashti M, Vosoughi R, Abtahi SH, Ramagopalan SV, Nasr Z.


An epidemiological study of neuromyelitis optica in Isfahan.
Mult Scler. 2014 Dec;20(14):1920-2. doi: 10.1177/1352458514537699. Epub 2014 Jun 2. No abstract available. 

Hecham N, Nouioua S, Sifi Y, Toubal N, Aissa LA, Hattab S, Batsi D, Hamimed A, Berkane F, Oudrer N, Aidi A, Abrouk S, Daoudi S, Hamri A, Assami S, Tazir M.


Multiple sclerosis: progression rate and severity in a multicenter cohort from Algeria.
Mult Scler. 2014 Dec;20(14):1923-4. doi: 10.1177/1352458514543343. Epub 2014 Aug 13. No abstract available. 

Heydarpour P, Amini H, Khoshkish S, Seidkhani H, Sahraian MA, Yunesian M.


Potential impact of air pollution on multiple sclerosis in Tehran, Iran.
Neuroepidemiology. 2014;43(3-4):233-8. doi: 10.1159/000368553. Epub 2014 Dec 9.

Etemadifar M, Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Nasr Z.


Estimated prevalence and incidence of multiple sclerosis in iran.
Eur Neurol. 2014;72(5-6):370-4. doi: 10.1159/000365846. Epub 2014 Oct 18.

Abdelrahman HS, Selim HS, Hashish MH, Sultan LI.


Epstein-Barr virus in multiple sclerosis.
J Egypt Public Health Assoc. 2014 Aug;89(2):90-5. doi: 10.1097/01.EPX.0000452287.65133.fc.

Akhtar S, Alroughani R, Al-Shammari A, Al-Abkal J, Ayad Y.


Non-parametric analysis of seasonality in birth and multiple sclerosis risk in second generation of migrants in Kuwait.
BMC Neurol. 2014 Aug 26;14:170. doi: 10.1186/s12883-014-0170-7.

Saei M, Holakouie-Naieni K, Mostafavi E, Sahraian MA, Mahmoodi M, Mansournia MA, Hosseini A.


Spatial Analysis of Multiple Sclerosis Disease in Tehran Metropolitan Zone, Iran, 2001-2012. 
Iran J Public Health. 2014 May;43(5):621-9.

Yamout B, El-Salem K, Gebeily S, Khoury S, Abu Zeid N, Hamoulila K, Alhalabi MS, Hasan ZN, Al Hamadani H, Hamoodi H, Al Omar A, Dahdaleh M.


Multiple sclerosis in the Levant: a regional consensus statement.
Int J Neurosci. 2014 May;124(5):377-82. doi: 10.3109/00207454.2013.833198. Epub 2013 Sep 13.

Abdollahi F, Sajedi SA.


Correlation of multiple sclerosis (MS) incidence trends with solar and geomagnetic indices: Time to revise the method of reporting MS epidemiological data.
Iran J Neurol. 2014 Apr 3;13(2):64-9.

Alroughani R, Ahmed SF, Behbahani R, Khan R, Thussu A, Alexander KJ, Ashkanani A, Nagarajan V, Al-Hashel J.


Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.
Mult Scler. 2014 Apr;20(5):543-7. doi: 10.1177/1352458513504328. Epub 2013 Sep 11.

Heydarpour P, Mohammad K, Yekaninejad MS, Elhami SR, Khoshkish S, Sahraian MA.


Multiple sclerosis in Tehran, Iran: a joinpoint trend analysis.
Mult Scler. 2014 Apr;20(4):512. doi: 10.1177/1352458513494496. Epub 2013 Jul 8. No abstract available.

Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Hamidian Jahromi A, Aghighi M, Heidary A.


Significant increase in the prevalence of multiple sclerosis in iran in 2011.
Iran J Med Sci. 2014 Mar;39(2):152-3. No abstract available. 

Nikseresht A, Sharifian M, Hamidian Jahromi A.


Month of birth and the incidence of multiple sclerosis in southern iran.
Iran J Med Sci. 2014 Mar;39(2 Suppl):232-3. No abstract available. 

Harandi AA, Harandi AA, Pakdaman H, Sahraian MA.


Vitamin D and multiple sclerosis.
Iran J Neurol. 2014;13(1):1-6. Review.

Lamdhade S, Ashkanani A, Alroughani R.


Prevalence of Anti-JC Virus Antibody in Multiple Sclerosis Patients in Kuwait.
ISRN Neurol. 2014;2014:861091. doi: 10.1155/2014/861091.

Asadollahi S, Fakhri M, Heidari K, Zandieh A, Vafaee R, Mansouri B.


Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
J Clin Neurosci. 2013 Dec;20(12):1747-50. doi: 10.1016/j.jocn.2013.01.018. Epub 2013 Aug 20.

Bohlega S, Inshasi J, Al Tahan AR, Madani AB, Qahtani H, Rieckmann P.


Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
J Neurol. 2013 Dec;260(12):2959-63. doi: 10.1007/s00415-013-6876-4. Epub 2013 Mar 17. Review.

Etemadifar M, Abtahi SH, Akbari M, Murray RT, Ramagopalan SV, Fereidan-Esfahani M.


Multiple sclerosis in Isfahan, Iran: an update.
Mult Scler. 2013 Dec 10;20(8):1145-1147. [Epub ahead of print] No abstract available. 

Sahraian MA, Jafarian S, Sheikhbahaei S, Safavi F.


Respiratory tract rather than cutaneous atopic allergy inversely associate with multiple sclerosis: a case-control study.
Clin Neurol Neurosurg. 2013 Oct;115(10):2099-102. doi: 10.1016/j.clineuro.2013.07.028. Epub 2013 Aug 17.

Sharafaddinzadeh N, Moghtaderi A, Majdinasab N, Dahmardeh M, Kashipazha D, Shalbafan B.


The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Clin Neurol Neurosurg. 2013 Aug;115(8):1271-5. doi: 10.1016/j.clineuro.2012.11.027. Epub 2012 Dec 27.

Roudbari SA, Ansar MM, Yousefzad A.


Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
J Neurol Sci. 2013 Jul 15;330(1-2):52-5. doi: 10.1016/j.jns.2013.04.003. Epub 2013 Apr 26.

Immunology and Pathology

Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.

Etesam Z, Nemati M, Ebrahimizadeh MA, Ebrahimi HA, Hajghani H, Khalili T, Frootan R, Zinoddini N, Jafarzadeh A.

J Mol Neurosci. 2016 Jul 2. [Epub ahead of print].
Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.

Mosayebi G, Soleyman MR, Khalili M, Mosleh M, Palizvan MR.

Int Neurourol J. 2016 Mar;20(1):26-32. doi: 10.5213/inj.1632514.257. Epub 2016 Mar 28.
Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.

Emamgholipour S, Hossein-Nezhad A, Sahraian MA, Askarisadr F, Ansari M.

Life Sci. 2016 Jan 15;145:34-41. doi: 10.1016/j.lfs.2015.12.014. Epub 2015 Dec 8.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.

Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Mahmoudi M.

Nanomedicine. 2016 Apr 21. pii: S1549-9634(16)30028-4. doi: 10.1016/j.nano.2016.04.001. [Epub ahead of print].
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.

Naderi S, Hejazi Z, Shajarian M, Alsahebfosoul F, Etemadifar M, Sedaghat N.

J Immunoassay Immunochem. 2016 Jun 1. [Epub ahead of print]
Immunomodulatory Effect of Chymotrypsin in CNS Is Sex-independent: Evidence of Anti-inflammatory Role for IL-17 in EAE.

Ghaffarinia A, Parvaneh S, Jalili C, Riazi-Rad F, Yaslianifard S, Pakravan N.

Iran J Allergy Asthma Immunol. 2016 Apr;15(2):145-55.
IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.

Ghalamfarsa G, Mahmoudi M, Mohammadnia-Afrouzi M, Yazdani Y, Anvari E, Hadinia A, Ghanbari A, Setayesh M, Yousefi M, Jadidi-Niaragh F.

J Immunotoxicol. 2016 May;13(3):274-85. doi: 10.3109/1547691X.2015.1089343. Epub 2015 Oct 28.
Increased Concentrations of Interleukin-33 in the Serum and Cerebrospinal Fluid of Patients with Multiple Sclerosis.

Jafarzadeh A, Mahdavi R, Jamali M, Hajghani H, Nemati M, Ebrahimi HA.

Oman Med J. 2016 Jan;31(1):40-5. doi: 10.5001/omj.2016.08.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.

Ahmadian-Elmi M, Bidmeshki Pour A, Naghavian R, Ghaedi K, Tanhaei S, Izadi T, Nasr-Esfahani MH.

Immunogenetics. 2016 Jan;68(1):43-54. doi: 10.1007/s00251-015-0881-y. Epub 2015 Nov 13.
Multiple sclerosis influences on the augmentation of serum Klotho concentration.

Ahmadi M, Emami Aleagha MS, Harirchian MH, Yarani R, Tavakoli F, Siroos B.

J Neurol Sci. 2016 Mar 15;362:69-72. doi: 10.1016/j.jns.2016.01.012. Epub 2016 Jan 6.
New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis.

Khorramdelazad H, Bagheri V, Hassanshahi G, Zeinali M, Vakilian A.

J Neuroimmunol. 2016 Jan 15;290:70-5. doi: 10.1016/j.jneuroim.2015.11.021. Epub 2015 Nov 24. Review.
Regulatory T cell number in multiple sclerosis patients: A meta-analysis.

Noori-Zadeh A, Mesbah-Namin SA, Bistoon-Beigloo S, Bakhtiyari S, Abbaszadeh HA, Darabi S, Rajabibazl M, Abdanipour A.

Mult Scler Relat Disord. 2016 Jan;5:73-6. doi: 10.1016/j.msard.2015.11.004. Epub 2015 Nov 10.
Role of orexin-A in experimental autoimmune encephalomyelitis.

Fatemi I, Shamsizadeh A, Ayoobi F, Taghipour Z, Sanati MH, Roohbakhsh A, Motevalian M.

J Neuroimmunol. 2016 Feb 15;291:101-9. doi: 10.1016/j.jneuroim.2016.01.001. Epub 2016 Jan 8.
Role of Proangiogenic Factors in Immunopathogenesis of Multiple Sclerosis.

Hamid KM, Mirshafiey A.

Iran J Allergy Asthma Immunol. 2016 Feb;15(1):1-12.
Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin.

Salehi M, Bagherpour B, Shayghannejad V, Mohebi F, Jafari R.

Iran J Immunol. 2016 Jun;13(2):141-7. doi: IJIv13i2A7.
The Molecular Mechanisms of Vitamin A Deficiency in Multiple Sclerosis.

Reza Dorosty-Motlagh A, Mohammadzadeh Honarvar N, Sedighiyan M, Abdolahi M.

J Mol Neurosci. 2016 Jun 29. [Epub ahead of print]
The Effects of IFN-β 1a on the Expression of Inflammasomes and Apoptosis-Associated Speck-Like Proteins in Multiple Sclerosis Patients.

Noroozi S, Meimand HA, Arababadi MK, Nakhaee N, Asadikaram G.

Mol Neurobiol. 2016 Mar 31. [Epub ahead of print]
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.

Safarzadeh E, Jadidi-Niaragh F, Motallebnezhad M, Yousefi M.

Inflamm Res. 2016 Jul;65(7):511-20. doi: 10.1007/s00011-016-0936-z. Epub 2016 Mar 9. Review.
Oct4 transcription factor in conjunction with valproic acid accelerates myelin repair in demyelinated optic chiasm in mice.

Dehghan S, Hesaraki M, Soleimani M, Mirnajafi-Zadeh J, Fathollahi Y, Javan M.

Neuroscience. 2016 Mar 24;318:178-89. doi: 10.1016/j.neuroscience.2016.01.028. Epub 2016 Jan 22.
Abdolahi M, Yavari P, Honarvar NM, Bitarafan S, Mahmoudi M, Saboor-Yaraghi AA.

Molecular Mechanisms of the Action of Vitamin A in Th17/Treg Axis in Multiple Sclerosis.

J Mol Neurosci. 2015 Dec;57(4):605-13. doi: 10.1007/s12031-015-0643-1. Epub 2015 Aug 30.
Emamgholipour S, Hossein-Nezhad A, Sahraian MA, Askarisadr F, Ansari M.

Evidence for possible role of melatonin in reducing oxidative stress in multiple sclerosis through its effect on SIRT1 and antioxidant enzymes.

Life Sci. 2015 Dec 8. pii: S0024-3205(15)30109-0. doi: 10.1016/j.lfs.2015.12.014. [Epub ahead of print]
Fereidan-Esfahani M, Brück W, Weber MS.

Targeting Central Nervous System B Cells in Progression of Multiple Sclerosis: Is Intrathecal Anti-CD20 a Therapeutic Option?

JAMA Neurol. 2015 Dec 1;72(12):1407-8. doi: 10.1001/jamaneurol.2015.2869. No abstract available.
Mohajeri M, Sadeghizadeh M, Javan M.

Pertussis toxin promotes relapsing-remitting experimental autoimmune encephalomyelitis in Lewis rats.

J Neuroimmunol. 2015 Dec 15;289:105-10. doi: 10.1016/j.jneuroim.2015.10.012. Epub 2015 Nov 11.
Nosratabadi R, Rastin M, Sankian M, Haghmorad D, Tabasi N, Zamani S, Aghaee A, Salehipour Z, Mahmoudi M.

St. John's wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells.

J Immunotoxicol. 2015 Dec 3:1-11. [Epub ahead of print]
Ahmadian-Elmi M, Bidmeshki Pour A, Naghavian R, Ghaedi K, Tanhaei S, Izadi T, Nasr-Esfahani MH.

miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.

Immunogenetics. 2015 Nov 13. [Epub ahead of print]
Al-Jaderi Z, Maghazachi AA.

Vitamin D₃ and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis.

Toxins (Basel). 2015 Nov 13;7(11):4730-44. doi: 10.3390/toxins7114730.
Vafaeyan H, Ebrahimzadeh SA, Rahimian N, Alavijeh SK, Madadi A, Faeghi F, Harirchian MH, Rad HS.

Quantification of diagnostic biomarkers to detect multiple sclerosis lesions employing 1H-MRSI at 3T.

Australas Phys Eng Sci Med. 2015 Nov 2. [Epub ahead of print]
Azin M, Mirnajafi-Zadeh J, Javan M.

Fibroblast Growth Factor-2 Enhanced The Recruitment of Progenitor Cells and Myelin Repair in Experimental Demyelination of Rat Hippocampal Formations.

Cell J. 2015 Fall;17(3):540-456. Epub 2015 Oct 7.
Ghalamfarsa G, Mahmoudi M, Mohammadnia-Afrouzi M, Yazdani Y, Anvari E, Hadinia A, Ghanbari A, Setayesh M, Yousefi M, Jadidi-Niaragh F.

IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis.

J Immunotoxicol. 2015 Oct 28:1-12. [Epub ahead of print]
Ramroodi N, Khani M, Ganjali Z, Javan MR, Sanadgol N, Khalseh R, Ravan H, Sanadgol E, Abdollahi M.

Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model ofMultiple Sclerosis.

Immunol Invest. 2015 Oct;44(7):694-712. doi: 10.3109/08820139.2015.1085391.

Rezapour-Firouzi S, Arefhosseini SR, Ebrahimi-Mamaghani M, Baradaran B, Sadeghihokmabad E, Mostafaei S, Torbati M, Chehreh M.

Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.

Complement Ther Med. 2015 Oct;23(5):652-7. doi: 10.1016/j.ctim.2015.07.003. Epub 2015 Jul 17.


Ashtari F, Toghianifar N, Zarkesh-Esfahani SH, Mansourian M. Short-Term Effect of High-Dose Vitamin D on the Level of Interleukin 10 in Patients with Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Neuroimmunomodulation. 2015;22(6):400-4. doi: 10.1159/000439278. Epub 2015 Sep 25.


Nejati A, Shoja Z, Shahmahmoodi S, Tafakhori A, Mollaei-Kandelous Y, Rezaei F, Hamid KM, Mirshafiey A, Doosti R, Sahraian MA, Mahmoudi M, Shokri F, Emery V, Marashi SM.

EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.

Med Microbiol Immunol. 2015 Sep 13. [Epub ahead of print]

Toghianifar N, Ashtari F, Zarkesh-Esfahani SH, Mansourian M.


Effect of high dose vitamin D intake on interleukin-17 levels in multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
J Neuroimmunol. 2015 Aug 15;285:125-8. doi: 10.1016/j.jneuroim.2015.05.022. Epub 2015 Jun 12.

Kishk NA, Abokrysha NT, Rashed L, Ahmed N.


Diagnostic value of aquaporin 4 antibody in assessing idiopathic inflammatory demyelinating central nervous system diseases in Egyptian patients.
J Clin Neurosci. 2015 Apr;22(4):670-5. doi: 10.1016/j.jocn.2014.09.024. Epub 2015 Feb 9.

Najafipoor A, Roghanian R, Zarkesh-Esfahani SH, Bouzari M, Etemadifar M.


The beneficial effects of vitamin D3 on reducing antibody titers against Epstein-Barr virus in multiple sclerosis patients.
Cell Immunol. 2015 Mar;294(1):9-12. doi: 10.1016/j.cellimm.2015.01.009. Epub 2015 Jan 28.

Razavi S, Nazem G, Mardani M, Esfandiari E, Salehi H, Esfahani SH.


Neurotrophic factors and their effects in the treatment of multiple sclerosis. 
Adv Biomed Res. 2015 Feb 17;4:53. doi: 10.4103/2277-9175.151570. eCollection 2015. Review.

Taha S, Aljishi M, Alsharoqi I, Bakhiet M.


Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
Biomed Rep. 2015 Jan;3(1):98-104. Epub 2014 Nov 17.

Soleimani M, Jameie SB, Barati M, Mehdizadeh M, Kerdari M.


Effects of coenzyme Q10 on the ratio of TH1/TH2 in experimental autoimmune encephalomyelitis model of multiple sclerosis in C57BL/6.
Iran Biomed J. 2014;18(4):203-11.

Moawad EY.


Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Indian J Clin Biochem. 2014 Oct;29(4):491-5. doi: 10.1007/s12291-013-0387-z. Epub 2013 Sep 28.

Haghmorad D, Mahmoudi MB, Mahmoudi M, Rab SZ, Rastin M, Shegarfi H, Azizi G, Mirshafiey A.


Calcium intervention ameliorates experimental model of multiple sclerosis.
Oman Med J. 2014 May;29(3):185-9. doi: 10.5001/omj.2014.46.

Messaoudani N, Djidjik R, Ghaffor M.


Comments on CSF κFLC assay evaluation in assessing intrathecal synthesis.
J Neuroimmunol. 2014 Jan 15;266(1-2):89. doi: 10.1016/j.jneuroim.2013.11.008. Epub 2013 Dec 6. No abstract available. 

Moghaddasi M, Mamarabadi M, Mohebi N, Razjouyan H, Aghaei M.


Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: a case control study.
Clin Neurol Neurosurg. 2013 Sep;115(9):1802-5. doi: 10.1016/j.clineuro.2013.05.007. Epub 2013 Jun 10.

  1   2   3   4


The database is protected by copyright ©dentisty.org 2016
send message

    Main page